what is the new glp 1 drug Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (2020–2025): IP and Science Signal Next New oral GLP-1 drug delivers

C.Crdenas-MezaM

By blocking NNMT, 5-Amino-1MQ helps restore cellular balance and metabolic output

Historical research on GHK-Cu's biological functions The review consolidates findings from laboratory studies, animal models, and human clinical trials spanning from the 1980s to 2018

Administration of NatuREN G, an innovative synbiotics mixture comprising Bifidobacterium animalis , BLC1 (10 9 cells), Lacticaseibacillus casei , LC4P1 (10 9 cells), fructooligosaccharides (2.5 g), inulin (2.5 g), quercetin (640 mg), resveratrol (230 mg), and proanthocyanidins (13 mg) to stages IIIb-IV CKD patients for 3 months reveal an increase in the ratio of Firmicutes/Bacteriodetes in the synbiotic group (Celano et al., 2023)